Book CD20 B-Cell Test | Lahalak Medical Platform
A cornerstone in lymphoma diagnosis, this test identifies the B-cell origin of tumors, enabling targeted therapies and personalized treatment plans essential for managing various types of blood cancers.
Scientific name: Immunohistochemistry (IHC) for CD20 (B-Cell)
Immunohistochemistry (IHC) for the CD20 marker is a technique using antibodies to detect the presence of CD20 protein on the cell surface. CD20 is a highly specific marker for most stages of B-cell development, making it a fundamental diagnostic tool in classifying B-cell lymphomas and assessing B-cell density in autoimmune diseases or chronic infl...
Included Services
- Detailed analysis for CD20 protein detection in tissue samples
- Consultation on results interpretation with a pathologist
- Personal support services from Lehlek
Medical Service Information
Conditions & Notices
- Fasting is not required, as the sample needed is a tissue sample (biopsy).
- The biopsy sample must be properly preserved in 10% formalin solution and encased in paraffin.
- Attach the clinical report and the suspected physician's diagnosis to ensure accurate interpretation.
- Please note that the waiting time for results may be longer than for routine analyses due to the complexity of the histological processing.